SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
11-Oct-23 10:02 AM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 10-Oct-23 | Grant | 85,000 | -- | -- | 37% 227.02K to 312.02K | |
11-Oct-23 10:02 AM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 10-Oct-23 | Disposition (change in control) | 312,018 | -- | -- | (100%) 312.02K to 0 | |
17-Feb-23 4:21 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 15-Feb-23 | Sale | 3,173 | $0.54 | $1,719.13 | (1%) 230.19K to 227.02K | |
09-Feb-23 5:09 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 08-Feb-23 | Payment of Exercise | 5,463 | $0.60 | $3,258.68 | (2%) 235.65K to 230.19K | |
09-Feb-23 5:09 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 07-Feb-23 | Grant | 18,864 | -- | -- | 9% 216.79K to 235.65K | |
02-Feb-23 8:12 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 01-Feb-23 | Payment of Exercise | 5,841 | $0.60 | $3,476.56 | (3%) 222.63K to 216.79K | |
02-Feb-23 8:12 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 31-Jan-23 | Grant | 17,631 | -- | -- | 9% 205.0K to 222.63K | |
25-Jan-23 5:30 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 24-Jan-23 | Grant | 170,000 | -- | -- | 486% 35.0K to 205.0K | |
15-Feb-22 4:13 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 14-Feb-22 | Grant | 35,000 | -- | -- | 100% 0 to 35.0K | |
15-Dec-20 6:20 AM View: | Oncocyte Corp (OCX) | 11-Dec-20 | Grant | 5,586 | -- | -- | 112% 5.0K to 10.59K | |
05-Aug-20 7:36 PM View: | Oncocyte Corp (OCX) | 03-Aug-20 | Market Purchase | 5,000 | $1.33 | $6,648.00 | 100% 0 to 5.0K | 77% |